Angiotensin II-Induced Signaling Pathways in Diabetes

Authors: Marrero, Mario B.; Fulton, David; Stepp, David; Stern, David M.

Source: Current Diabetes Reviews, Volume 1, Number 2, June 2005 , pp. 197-202(6)

Publisher: Bentham Science Publishers

Buy & download fulltext article:

Price: $62.88 plus tax (Refund Policy)

Abstract:

Excessive cellular proliferation is a major contributor to the pathological changes associated with the secondary complications of diabetes. In particular, hyperglycemia (HG)-induced growth of vascular smooth muscle cells (VSMC) and glomerular mesangial cells (GMC) are characteristic features of the cardiovascular and renal complications of diabetes. VSMC and GMC respond to traditional growth factors, however in diabetes this occurs in the context of an environment, enriched in circulating vasoactive mediators and HG. For example, signaling via the angiotensin II (Ang II) pathway has been implicated in the pathogenesis of diabetic vascular disease. Recent findings indicate that HG and Ang II activate intracellular processes, including the polyol pathway and the generation of reactive oxygen species. These pathways activate the JAK (janus kinase)/STAT (signal transducers and activators of transcription) signaling cascades in both VSMC and GMC. Activation of the latter signaling cascade can stimulate excessive proliferation and growth of these cells, contributing to the accelerated atherosclerosis and nephropathy seen in the diabetic state. This review focuses on key factors in the diabetic microenvironment, in particular the interplay between HG, accumulation of advanced glycation end products and Ang II mediated signaling events both in vitro and in vivo.

Keywords: angiotensin II; jak; hyperglycemia; vascular smooth muscle cells; stat; glomerular mesangial cells

Document Type: Review article

DOI: http://dx.doi.org/10.2174/1573399054022802

Affiliations: 1: Vascular Biology Center, Medical College of Georgia, Augusta, Georgia 30912-2500, USA.

Publication date: 2005-06-01

More about this publication?

Current Diabetes Reviews publishes frontier reviews on all the latest advances on diabetes and its related areas e.g. pharmacology, pathogenesis, complications, epidemiology, clinical care, and therapy.

The journal's aim is to publish the highest quality review articles dedicated to clinical research in the field. The journal is essential reading for all researchers and clinicians who are involved in the field of diabetes.

Angiotensin II-Induced Signaling Pathways in Diabetes

Buy & download fulltext article:

Tools

Key

Text size:

Useful pages